Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer
NCT00622622
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL:
VEGFR2-169 and gemcitabine
Sponsor
Wakayama Medical University
Collaborators
[object Object]